Truist Financial Maintains Omega Healthcare Investors Inc(OHI.US) With Hold Rating
Scotiabank Maintains Omega Healthcare Investors Inc(OHI.US) With Hold Rating, Maintains Target Price $39
BMO Capital Maintains Omega Healthcare Investors Inc(OHI.US) With Buy Rating, Cuts Target Price to $42
Omega Healthcare Invts Analyst Ratings
Wells Fargo Downgrades Omega Healthcare Investors Inc(OHI.US) to Hold Rating, Cuts Target Price to $39
Truist Financial Maintains Omega Healthcare Investors Inc(OHI.US) With Hold Rating, Announces Target Price $39
Truist Lifts Price Target on Omega Healthcare Investors to $39 From $38, Keeps Hold Rating
Omega Healthcare Is Maintained at Overweight by Wells Fargo
Omega Healthcare Invts Analyst Ratings
Wells Fargo Maintains Omega Healthcare Investors Inc(OHI.US) With Buy Rating, Cuts Target Price to $41
RBC Capital Maintains Omega Healthcare Investors Inc(OHI.US) With Hold Rating, Cuts Target Price to $39
Wedbush Maintains Omega Healthcare Investors Inc(OHI.US) With Hold Rating, Raises Target Price to $38
BofA Securities Maintains Omega Healthcare Investors Inc(OHI.US) With Hold Rating
Omega Healthcare Invts Analyst Ratings
JMP Securities Maintains Omega Healthcare Investors Inc(OHI.US) With Hold Rating
Truist Financial Maintains Omega Healthcare Investors Inc(OHI.US) With Hold Rating
Scotiabank Maintains Omega Healthcare Investors Inc(OHI.US) With Hold Rating, Maintains Target Price $39
Mizuho Securities Maintains Omega Healthcare Investors Inc(OHI.US) With Hold Rating
BMO Capital Maintains Omega Healthcare Investors Inc(OHI.US) With Buy Rating, Maintains Target Price $45
Berenberg Bank Maintains Omega Healthcare Investors Inc(OHI.US) With Buy Rating, Maintains Target Price $45